Wiley.com

User login

Vitamin Therapy May Help Prevent Melanoma

A new review highlights the potential of nicotinamide (Vitamin B3) for preventing melanoma in high-risk individuals.

Wednesday, August 9, 2017 12:01 am EDT
"Nicotinamide has been show in a clinical trial—called ONTRAC—to reduce the incidence of non-melanoma skin cancer in high-risk individuals and it would be worthwhile to determine whether it would also be useful for high-risk melanoma patients"

A new review highlights the potential of nicotinamide (Vitamin B3) for preventing melanoma in high-risk individuals.

Nicotinamide can help reduce or reverse DNA damage, inflammation, and immunosuppression caused by ultraviolet radiation.

The cost of nicotinatimide is approximately $10 per month if taken at 1g per day as recommended. Randomized placebo controlled trials are now warranted to determine its efficacy and safety for melanoma prevention.

“Nicotinamide has been show in a clinical trial—called ONTRAC—to reduce the incidence of non-melanoma skin cancer in high-risk individuals and it would be worthwhile to determine whether it would also be useful for high-risk melanoma patients,” said Dr. Gary Halliday, senior author of the Photodermatology, Photoimmunology & Photomedicine review.

Additional Information

Link to Studyhttp://onlinelibrary.wiley.com/doi/10.1111/phpp.12328/full

About Journal

The journal is a forum for new information about the direct and distant effects of electromagnetic radiation (ultraviolet, visible and infrared) mediated through skin. The divisions of the editorial board reflect areas of specific interest: aging, carcinogenesis, immunology, instrumentation and optics, lasers, photodynamic therapy, photosensitivity, pigmentation and therapy. Photodermatology, Photoimmunology & Photomedicine includes original articles, reviews, communications and editorials.

Multimedia Files:

Preview image

Contact:

Penny Smith
+44 (0) 1243 770448
sciencenewsroom@wiley.com